CNS & Neurological Disorders - Drug Targets
Title:Editorial: Combining Forces to Improve Alzheimer’s Disease Drug Discovery: The Symptomatic Battle
Volume: 15 Issue: 7
Author(s): Julie Deguil, Alexandra Auffret, Esther Schenker, Fabienne Aujard, Yves Lamberty, David Bartrès-Faz, Olivier Blin, Joëlle Micallef, Jill C. Richardson and Régis Bordet
Affiliation:
Export Options
About this article
Cite this article as:
Deguil Julie, Auffret Alexandra, Schenker Esther, Aujard Fabienne, Lamberty Yves, Bartrès-Faz David, Blin Olivier, Micallef Joëlle, Richardson C. Jill and Bordet Régis, Editorial: Combining Forces to Improve Alzheimer’s Disease Drug Discovery: The Symptomatic Battle, CNS & Neurological Disorders - Drug Targets 2016; 15 (7) . https://dx.doi.org/10.2174/187152731507160808200737
DOI https://dx.doi.org/10.2174/187152731507160808200737 |
Print ISSN 1871-5273 |
Publisher Name Bentham Science Publisher |
Online ISSN 1996-3181 |
Call for Papers in Thematic Issues
Trends and perspectives in the rational management of CNS disorders
Central nervous system (CNS) diseases enforce a significant global health burden, driving ongoing efforts to improve our understanding and effectiveness of therapy. This issue investigates current advances in the discipline, focusing on the understanding as well as therapeutic handling of various CNS diseases. The issue covers a variety of diseases, ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Who’s the Leader, Mania or Depression? Predominant Polarity and Alcohol/Polysubstance Use in Bipolar Disorders
Current Neuropharmacology Prevention of Non-communicable Diseases by Balanced Nutrition: Population- specific Effective Public Health Approaches in Developing Countries
Current Diabetes Reviews Cutting-edge Patents in Alzheimers Disease Drug Discovery: Anticipation of Potential Future Treatments
Recent Patents on CNS Drug Discovery (Discontinued) Obesity and Arterial Compliance Alterations
Current Vascular Pharmacology Hypothalamic and Neuroendocrine Changes in Huntingtons Disease
Current Drug Targets Design and Synthesis of Benzopyranopyrimidinyl Phosphonates as Cytotoxic and Antioxidant Agents
Letters in Drug Design & Discovery TRPV1 Function in Health and Disease
Current Pharmaceutical Biotechnology Anti-Amyloidogenic and Anti-Apoptotic Role of Melatonin in Alzheimer Disease
Current Neuropharmacology Meet Our Editorial Board Member:
Current Neuropharmacology Do Pharmacological Approaches that Prevent Opioid Tolerance Target Different Elements in the Same Regulatory Machinery?
Current Drug Abuse Reviews The Therapeutic Community for the Adolescent Substance Abuser
Adolescent Psychiatry Cross-Cultural Comparison of Mild Cognitive Impairment between China and USA
Current Alzheimer Research Conference Report (The XVth International Symposium of Brain Edema and Cellular Injury)
CNS & Neurological Disorders - Drug Targets Acknowledgements to Reviewers:
Central Nervous System Agents in Medicinal Chemistry Evaluation of Selected Natural Compounds as Dual Inhibitors of Catechol-O-Methyltransferase and Monoamine Oxidase
Central Nervous System Agents in Medicinal Chemistry Tuftsin – Properties and Analogs
Current Medicinal Chemistry Oxidative Stress Mediated Mitochondrial and Vascular Lesions as Markers in the Pathogenesis of Alzheimer Disease
Current Medicinal Chemistry Inflammation as a Therapeutic Target for Various Deadly Disorders: A Review
Current Drug Targets Principal Component Structuring of the Non-REM Sleep EEG Spectrum in Older Adults Yields Age-Related Changes in the Sleep and Wake Drives
Current Aging Science Interactions between Ketamine and Magnesium for the Treatment of Pain: Current State of the Art
CNS & Neurological Disorders - Drug Targets